Assessing outcomes of acute myocarditis in Saudi Arabia

References

1. 1.↵
   1. Lampejo T,
   2. Durkin SM,
   3. Bhatt N,
   4. Guttmann O

   . Acute myocarditis: aetiology, diagnosis and management. Clinical Medicine 2021; 21: e505-e510.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Ali M,
   2. Shiwani HA,
   3. Elfaki MY,
   4. Hamid M,
   5. Pharithi R,
   6. Kamgang R, et al.

   COVID-19 and myocarditis: a review of literature. Egypt Heart J 2022; 74: 23.

   OpenUrlPubMed
3. 3.↵
   1. Olejniczak M,
   2. Schwartz M,
   3. Webber E,
   4. Shaffer A,
   5. Perry TE

   . Viral myocarditis—incidence, diagnosis and management. J Cardiothorac Vasc Anesth 2020; 34: 1591-601.

   OpenUrlPubMed
4. 4.↵
   1. Tschöpe C,
   2. Ammirati E,
   3. Bozkurt B,
   4. Caforio AL,
   5. Cooper LT,
   6. Felix SB, et al.

   Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021; 18: 169-193.

   OpenUrlPubMed
5. 5.↵
   1. Cooper LT,
   2. McKenna WJ,
   3. Yeon SB

   UpToDate. Cooper LT, McKenna WJ, Yeon SB. Clinical manifestations and diagnosis of myocarditis in adults. [Updated 2024 May 7; Accessed 2011 Sep 19]. Available from: https://www.uptodate.cn/contents/clinical-manifestations-and-diagnosis-of-myocarditis-in-adults
6. 6.↵
   1. Albuali WH,
   2. Al-Qahtani MH,
   3. Yousef AA,
   4. Al Ghamdi MA,
   5. AlQurashi FO,
   6. Lardhi AA, et al.

   Myocarditis in children: impact of early presentation on disease outcomes at a single tertiary center in Saudi Arabia. Int J Gen Med 2022: 5627-5633.
7. 7.↵
   1. Ferreira VM,
   2. Schulz-Menger J,
   3. Holmvang G,
   4. Kramer CM,
   5. Carbone I,
   6. Sechtem U, et al.

   Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018; 72: 3158-3176.

   OpenUrlFREE Full Text
8. 8.↵
   1. Younis A,
   2. Matetzky S,
   3. Mulla W,
   4. Masalha E,
   5. Afel Y,
   6. Chernomordik F, et al.

   Epidemiology characteristics and outcome of patients with clinically diagnosed acute myocarditis. Am J Med 2020; 133: 492-499.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Ammirati E,
   2. Cipriani M,
   3. Moro C,
   4. Raineri C,
   5. Pini D,
   6. Sormani P, et al.

   Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry. Circulation 2018; 138: 1088-1099.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Ammirati E,
    2. Veronese G,
    3. Brambatti M,
    4. Merlo M,
    5. Cipriani M,
    6. Potena L, et al.

    Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2019; 74: 299-311.

    OpenUrlFREE Full Text
11. 11.↵
    1. Bohbot Y,
    2. Garot J,
    3. Hovasse T,
    4. Unterseeh T,
    5. Di Lena C,
    6. Boukefoussa W, et al.

    Clinical and cardiovascular magnetic resonance predictors of early and long-term clinical outcome in acute myocarditis. Front Cardiovasc Med 2022; 9: 886607.

    OpenUrlPubMed
12. 12.↵
    1. Sanguineti F,
    2. Garot P,
    3. Mana M,
    4. O’h-Ici D,
    5. Hovasse T,
    6. Unterseeh T, et al.

    Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson 2015; 17: 78.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Caforio AL,
    2. Calabrese F,
    3. Angelini A,
    4. Tona F,
    5. Vinci A,
    6. Bottaro S, et al.

    A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 2007; 28: 1326-1333.

    OpenUrlCrossRefPubMed
14. 14.
    1. Kindermann I,
    2. Kindermann M,
    3. Kandolf R,
    4. Klingel K,
    5. Bültmann B,
    6. Müller T, et al.

    Predictors of outcome in patients with suspected myocarditis. Circulation 2008; 118: 639-648.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Grün S,
    2. Schumm J,
    3. Greulich S,
    4. Wagner A,
    5. Schneider S,
    6. Bruder O, et al.

    Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012; 59: 1604-1615.

    OpenUrlFREE Full Text
16. 16.↵
    1. McCarthy RE,
    2. Boehmer JP,
    3. Hruban RH,
    4. Hutchins GM,
    5. Kasper EK,
    6. Hare JM, et al.

    Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690-695.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Magnani JW,
    2. Danik HJ,
    3. Dec Jr GW,
    4. DiSalvo TG

    . Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J 2006; 151: 463-470.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Hang W,
    2. Chen C,
    3. Seubert JM,
    4. Wang DW

    . Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes. Signal Transduct Target Ther 2020; 5: 287.

    OpenUrlPubMed
19. 19.↵
    1. Knudsen B,
    2. Prasad V

    . COVID‐19 vaccine induced myocarditis in young males: A systematic review. Eur J Clin Invest 2023; 53: e13947.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Karlstad Ø,
    2. Hovi P,
    3. Husby A,
    4. Härkänen T,
    5. Selmer RM,
    6. Pihlström N, et al.

    SARS-CoV-2 vaccination and myocarditis in a Nordic cohort study of 23 million residents. JAMA Cardiol 2022; 7: 600-612.

    OpenUrlPubMed
21. 21.↵
    1. Boehmer TK

    . Association between COVID-19 and myocarditis using hospital-based administrative data—United States, March 2020–MMWR Morb Mortal Wkly Rep 2021;70: 1228-1232.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Patone M,
    2. Mei XW,
    3. Handunnetthi L,
    4. Dixon S,
    5. Zaccardi F,
    6. Shankar-Hari M, et al.

    Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation 2022; 146: 743-754.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Lai FT,
    2. Chan EW,
    3. Huang L,
    4. Cheung CL,
    5. Chui CS,
    6. Li X, et al.

    Prognosis of myocarditis developing after mRNA COVID-19 vaccination compared with viral myocarditis. J Am Coll Cardiol 2022; 80: 2255-2265.

    OpenUrlPubMed
24. 24.↵
    1. Voleti N,
    2. Reddy SP,
    3. Ssentongo P

    . Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. Front Cardiovasc Med 2022; 9: 951314.

    OpenUrlPubMed